Group Research Brands Investor Relations Governance News Careers IT EN 11 OCTOBER 2021 STAR Conference Fall Edition 2021: PharmaNutra si confronta con analisti e investitori Sorry, this entry is only available in Italian.Dopo l’incontro di aprile in occasione della Spring Edition, dal 12 al 14 […] 30 AUGUST 2021 New PharmaNutra HQ: laying of the cornerstone and official start of construction With the groundbreaking of today, PharmaNutra S.p.A. officially begins the construction works of its new headquarters and pharmaceutical centre in […] 26 JULY 2021 SiderAL® Folico chosen as “product of the year for women of childbearing age” at the Supplement Awards 2021 The award was given to WinMedica, a longstanding partner of PharmaNutra, which deals with the distribution of SiderAL® Folico in […] 17 JUNE 2021 New PharmaNutra HQ: contract signed with SACAIM Construction work on PharmaNutra’s new pharmaceutical facility, assigned to the Venice-based general contractor SACAIM S.p.A. (Eccher Group), will commence in […] 09 JUNE 2021 PharmaNutra sponsors Pisa Sporting Club again for 2021-2022 Today PharmaNutra has officially announced their renewed partnership with Pisa Sporting Club, the soccer team managed by Giuseppe Corrado that will […] 12 MAY 2021 PharmaNutra joined TP ICAP Midcap Conference Over 180 international investors and 140 companies attended the event, in which Pharmanutra presented brilliant 2021 Q1 financial results to […] 24 MARCH 2021 STAR Conference Spring Edition 2021: PharmaNutra meets investors following its first STAR year The 2021 STAR Conference organised by Borsa Italiana is an opportunity to meet MTA investors following publication of the 2020 […] 15 MARCH 2021 Pisa University and PharmaNutra working together on the Marketing Project Work education plan The “Marketing Project Work” education plan, which challenged Pisa University students for the launch of a new PharmaNutra product, recently […] 09 FEBRUARY 2021 SiderAL® Forte 20 capsules confirmed the best-selling food supplement in Italy 2020 ended positively for Sucrosomial® iron-based products, which thanks to SiderAL® Forte have confirmed their market position. December’s market data*, […] 05 FEBRUARY 2021 Midcap analysis: PharmaNutra stronger than its peers. Assigned a buy rating with TP at 42 euro. On 5ᵗʰ February, Midcap produced the “Small Touch” survey highlighting how PharmaNutra is performing more consistently that its peers. As […] 20 JANUARY 2021 PharmaNutra participates in the Italian Mid Cap Conference 2021 The third edition of the Italian Mid Cap Conference, organised by Mediobanca officially opened yesterday, seeing the participation of top […] 22 DECEMBER 2020 Cetilar® Patch and Cetilar® Tape classified as Class 2A MD The Higher Institute for Health (ISS) has classified Cetilar® Patch and Cetilar® Tape as Class 2A Medical Devices, while the U.S. […] 1 2 … 11 > PharmaNutra Spa Registered office Via Delle Lenze, 216/b - 56122 Pisa Phone +39 050 7846500 Fax +39 050 7846524 Electronic billing code SUBM70N C.F. / P.Iva / Reg. Impr. 01679440501 Share capital € 1.123.097,70 I.V. | REA 146259 Contacts Info info@pharmanutra.it Commerciale commerciale@pharmanutra.it Investor relations investorrelation@pharmanutra.it Distribution internationaldept@pharmanutra.it Product sites sideral.it cetilar.it ultramag.it apportal.it NEWSLETTER Subscribe to the Pharmanutra newsletter and you will be constantly updated on all our activities. Read Newsletter Disclosure Subscribe to the newsletter PRIVACY POLICY COOKIE POLICY GENERAL CONDITIONS PRIVACY INFORMATION FOR CUSTOMERS CODE OF ETHICS 231 MODEL © 2020 PharmaNutra SpA - All rights reserved Informativa Noi e terze parti selezionate utilizziamo cookie o tecnologie simili per finalità tecniche e, con il tuo consenso, anche per altre finalità come specificato nella cookie policy. Scopri di più e personalizza Rifiuta Accetta